EN PL
ORIGINAL PAPER
Assessment of hospitalization and mortality of scleroderma in-patients: a thirteen-year study
 
More details
Hide details
 
Submission date: 2017-05-12
 
 
Final revision date: 2017-07-04
 
 
Acceptance date: 2017-08-02
 
 
Online publication date: 2017-08-31
 
 
Publication date: 2017-08-31
 
 
Reumatologia 2017;55(4):163-168
 
KEYWORDS
TOPICS
ABSTRACT
Objective: Systemic sclerosis (SSc) is an uncommon non-hereditary sporadic disease that increases the risk of premature death, especially in diffuse type. We determined the prevalence of SSc in the last 13 years in our rheumatologic hospitals as a referral center for southern Iranian patients, the causes of hospitalization, the average length of stay (LOS), the mortality rate, and the reason for their mortality.
Material and methods: A cross-sectional study was performed in Shiraz University of Medical Sciences, Iran. The studied population included all patients diagnosed with systemic sclerosis. We calculated the hospitalization rates, in-hospital mortality rates, and mean LOS.
Results: There were 446 admissions by 181 patients with SSc. The female to male ratio was about 10.7 : 1. The overall mean LOS was 5.95 days. Digital ulcer and interstitial lung disease (ILD) were the most common causes of hospitalizations among the SSc-related events. For those with a non-SSc-related condition, infection was the most prevalent event. Most of the deaths were due to ILD and pulmonary artery hypertension(PAH), and the overall in-hospital mortality rate was 16.5%.
Conclusions: Women with SSc had higher rates of hospitalization but lower in-hospital mortality than men.There were some differences between our study and other similar studies in the causes of hospitalization and in-hospital death among SSc patients, especially the lower age of death. The patients with digital ulcers and those with intestinal lung disease or pulmonary hipertension were most commonly admitted to the hospital in our study group. Probably, increasing the skin care of these patients and asking other specialty groups to cooperate will decrease the high rate of hospitalizations in our population.
REFERENCES (14)
1.
Medical Grand Rounds from the University of Alabama Medical Center. Lupus erythematosus. South Med J 1971; 64: 839-846.
 
2.
Yazawa N, Fujimoto M, Tamaki K. Recent advances on pathogenesis and therapies in systemic sclerosis. Clin Rev Allergy Immunol 2007; 33: 107-112.
 
3.
Chung L, Krishnan E, Chakravarty EF. Hospitalizations and mortality in systemic sclerosis: results from the Nationwide Inpatient Sample. Rheumatology (Oxford, England) 2007; 46: 1808-1813.
 
4.
Netwijitpan S, Foocharoen C, Mahakkanukrauh A, et al. Indications for hospitalization and in-hospital mortality in Thai systemic sclerosis. Clin Rheum 2013; 32: 361-367.
 
5.
Sehra ST, Kelly A, Baker JF, Derk CT. Predictors of inpatient mortality in patients with systemic sclerosis: a case control study. Clin Rheum 2016; 35: 1631-1635.
 
6.
Rubio-Rivas M, Simeon-Aznar CP, Velasco C, et al. Changes in the pattern of death of 987 patients with systemic sclerosis from 1990 to 2009 from the nationwide Spanish Scleroderma Registry (RESCLE). Clin Exp Rheumatol 2017.
 
7.
Shalev T, Haviv Y, Segal E, et al. Outcome of patients with scleroderma admitted to intensive care unit. A report of nine cases. Clin Exp Rheumatol 2006; 24: 380-386.
 
8.
Heijnen T, Wilmer A, Blockmans D, Henckaerts L. Outcome of patients with systemic diseases admitted to the medical intensive care unit of a tertiary referral hospital: a single-centre retrospective study. Scand J Rheum 2016; 45: 146-150.
 
9.
LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202-205.
 
10.
Nazarinia MA, Esmaeilzadeh E, Emami Y, Salehi A. One decade distinct features, morbidity and mortality of scleroderma: a cross-sectional study. Clin Exp Rheumatol 2016; 34 Suppl 100 (5): 74-78.
 
11.
Wielosz E, Majdan M, Dryglewska M, Suszek D. Comparison of clinical and serological parameters in female and male patients with systemic sclerosis. Reumatologia 2015; 53: 315-320.
 
12.
Piga M, Casula L, Sanna S, et al. Population-based analysis of hospitalizations for patients with systemic sclerosis in a West-European region over the period 2001–2012. Rheum Intern 2016; 36: 73-81.
 
13.
Ooi C, Solanki K. Mortality in the Waikato Hospital Systemic Sclerosis Cohort. Int J Rheum Dis 2017; doi: 10.1111/1756-185X.13111.
 
14.
Jacobsen S, Halberg P, Ullman S. Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma). Br J Rheum 1998; 37: 750-755.
 
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
eISSN:2084-9834
ISSN:0034-6233
Journals System - logo
Scroll to top